BS (yes, those are his initials) knows that The Carlyle Group now owns the shares and that they bought them from a certain activist investor who previously owned CHK stock until September 2016 but sold it all and then bought some bonds that would convert at around the same price as the "activist investor" liquidated. Now Carlyle owns them, much to the dismay of Morgan Stanley (who is short CHK). The activist investor was concerned that this information would become public which is why he also filed a CT a few months before liquidating his entire position.
3 replies (most recent on top)
The party who acquired the 250M shares will be known sometime during the week of November 15th, if not sooner. A large investor, possibly the acquirer of the new shares, bought/sold a huge number (150K+) of Nov 15 put contracts with a strike price of $1.00. I wonder what to think of this?
Carlyle has been very successful with their worldly purchases, so if they purchase enough stock to have a say so in CHK decisions, then it could increase the stock price to close to $10/share. Then a good chance to bail out some of our stock and have money for Christmas.
Wow transparency and open communication from this management team trying to spin as positive headline. Makes sense. Sad more lies and deceit from failing organization.